LIVN: Keybanc Raises Target
Keybanc maintains overweight rating on LivaNova and raises price target to $92
Keybanc Maintains Overweight on LivaNova, Raises Price Target to $92
Keybanc maintains overweight rating on LivaNova and raises price target to $92
Keybanc Maintains Overweight on LivaNova, Raises Price Target to $92